NPC-12G Gel 0.2% Sirolimus PK Bridging Study

NCT03972462 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability Study

Interventions

DRUG: NPC-12G Gel 0.2%
DRUG: Rapamune® 2 mg tablet

Sponsor

Nobelpharma